Dataset opportunity
Europlaz — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Europlaz, usable for Regulatory RAG and Compliance Copilots.
Score
63.7
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Regulatory Affairs market = $1.31 billion in 2024, CAGR 18.60%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
This dataset contains Text-based regulatory records from Europlaz, a medical device contract manufacturer. It includes a rich collection of `business_records`, `industrial_data`, and regulatory filings, providing detailed evidence of manufacturing processes, quality assurance, and compliance with standards like ISO 13485. This structured and unstructured data is highly suitable for training and fine-tuning a Regulatory RAG system to automate compliance checks and accelerate the generation of submission documents.
The global AI in Regulatory Affairs market was valued at $1.31 billion in 2024 and is projected to grow at a CAGR of 18.60% through 2033. Despite access complexities arising from split data ownership between Europlaz and its clients, and the rigorous data integrity required by regulations, this dataset is exceptionally valuable. The high-growth market underscores the intense demand for data that can streamline and de-risk the regulatory approval process, making negotiated access a strategic priority for AI developers in the MedTech space. ⚠ Diligence (valuable data, access to negotiate): Data ownership is likely split between Europlaz (process/telemetry) and their medical clients (product design); Strict regulatory compliance (ISO 13485) requires rigorous data integrity and may limit external sharing; Manufacturing data is likely stored in siloed ERP or Quality Management Systems (QMS) · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Europlaz holds a proprietary dataset of regulatory and quality documentation from its medical device manufacturing, including detailed traceability records. This is a high-value asset for RegTech and compliance-AI vendors seeking to train models for regulatory RAG applications. In a global AI in Regulatory Affairs market projected to grow at over 18% annually, this dataset offers a rare source of real-world, ISO 13485-compliant text data to build a competitive advantage.
See dimension details ↓- Dataset Specificity78
dominant 'regulatory', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is high, driven by the need to automate compliance and accelerate submissions in the rapidly growing AI in Regulatory Affairs market, which is expanding at a CAGR of 18.60%.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
surplus=medium — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ good target — Europlaz is a UK-based contract manufacturer of medical devices, making it a strong target that generates significant, dormant regulatory and manufacturing data as a by-product of its core operational business. Issues: Employee count data is inconsistent across sources, with one source citing 22 employees and another mentioning a '120-strong workforce'. The higher number is mo
- Deep Qualification80
✓ pass — Europlaz is a contract manufacturer for medical devices, making the existence of a 'Regulatory Records Dataset' highly plausible as a by-product. However, data ownership is mixed between Europlaz and its clients, and the confidential nature of the work makes third-party data licensing rights unclear and likely restricted by non-public agreements.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Industrial data
This evidence points to time-series data from the full-service manufacturing process, providing crucial operational context for the associated regulatory filings.
Regulatory records
This text data consists of comprehensive quality records and traceability logs maintained under the ISO 13485:2016 standard, representing a prime source for training and validating regulatory AI models.
business_records
These are structured documents detailing equipment and process validation services (IQ, OQ, PQ), offering granular, real-world examples of compliance procedures for AI training.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Europlaz Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Regulatory Affairs market = $1.31 billion in 2024, CAGR 18.60% (source: Grand View Research). Investment score 63.7/100 (confidence 0.49). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Endiatx — Medical Imaging Dataset Opportunity
View opportunity →healthcareAktiia — Sensor Telemetry Dataset Opportunity
View opportunity →mobilityDeringer — Regulatory Records Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read